Trial
NCT00745953
Regression of Fatty Heart by Valsartan Therapy
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Novartis Pharmaceuticals
Condition
Metabolic Syndrome
Intervention
Valsartan
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-17